Cargando…

Mecasermin for primary insulin-like growth factor-1 deficiency

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722352/
https://www.ncbi.nlm.nih.gov/pubmed/36479333
http://dx.doi.org/10.18773/austprescr.2022.077
_version_ 1784843954922979328
collection PubMed
description
format Online
Article
Text
id pubmed-9722352
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-97223522022-12-06 Mecasermin for primary insulin-like growth factor-1 deficiency Aust Prescr New Drugs NPS MedicineWise 2022-11-30 2022-12 /pmc/articles/PMC9722352/ /pubmed/36479333 http://dx.doi.org/10.18773/austprescr.2022.077 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Mecasermin for primary insulin-like growth factor-1 deficiency
title Mecasermin for primary insulin-like growth factor-1 deficiency
title_full Mecasermin for primary insulin-like growth factor-1 deficiency
title_fullStr Mecasermin for primary insulin-like growth factor-1 deficiency
title_full_unstemmed Mecasermin for primary insulin-like growth factor-1 deficiency
title_short Mecasermin for primary insulin-like growth factor-1 deficiency
title_sort mecasermin for primary insulin-like growth factor-1 deficiency
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722352/
https://www.ncbi.nlm.nih.gov/pubmed/36479333
http://dx.doi.org/10.18773/austprescr.2022.077